Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
12 pending office actions • 10 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Centre National De La Recherche Scientifique-Cnrs currently has 1 pending office action. This action is assigned to 1 distinct examiner, ZHANG, KELING NMN. The company's current engagement with the USPTO is limited to this single matter, which streamlines the administrative requirements of their prosecution.
ZHANG, KELING NMN is the busiest examiner for this portfolio, managing 1 pending office action. With only one examiner involved, the company can focus its efforts on the specific feedback and requirements of a single individual. This centralized approach avoids the complexities associated with managing multiple examiners or diverse technical units.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (33%) |
| §112 only | 2 (17%) |
| Multi-statute (no §101) | 6 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AYAD, TAMIR | 1 | 42.3% | +47.9% |
| MCINTOSH III, TRAVISS C | 1 | 73.2% | +14.0% |
| BELLAH, JEFFREY LAWRENCE | 1 | 100.0% | +0.0% |
| LADD, CAROLYN LOUISE | 1 | 58.6% | +47.1% |
| MILLER, MICHAEL G | 1 | 52.0% | +15.8% |
| WHITEMAN, BRIAN A | 1 | 68.5% | +16.7% |
| MCKENZIE, THOMAS B | 1 | 57.3% | +22.6% |
| SAWYER, JENNIFER C | 1 | 68.6% | -8.4% |
| WHITE, ASHLEY TAYLOR | 1 | 25.0% | +46.7% |
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013713 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | WHITE, ASHLEY TAYLOR | 19d |
| 19112100 | THERMOPLASMONIC DEVICE, RESPECTIVE WIRELESS ENERGY TRANSFER SYSTEM AND RESPECTIVE OPERATION METHOD | AYAD, TAMIR | — |
| 18714018 | INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION | MCINTOSH III, TRAVISS C | — |
| 18711813 | ATTACHING NUCLEIC ACIDS TO A PLATINUM ELECTRODE | BELLAH, JEFFREY LAWRENCE | — |
| 18686290 | METHOD FOR GENERATING NANOPARTICLES ON THE SURFACE OF A SUBSTRATE AND PART COMPRISING SUCH A SUBSTRATE | MILLER, MICHAEL G | — |
| 18546348 | A PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLAMINES FROM POLYFLUOROALKYLALCOHOLS | SAWYER, JENNIFER C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18289512 | MESOPOROUS SOLID FOR CONTROLLING HUMIDITY IN ENCLOSED SPACES | MCKENZIE, THOMAS B | 17d overdue |
| 18013713 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | WHITE, ASHLEY TAYLOR | 19d |
| 18001420 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT | NOTTINGHAM, KYLE GREGORY | 28d |
| 19112100 | THERMOPLASMONIC DEVICE, RESPECTIVE WIRELESS ENERGY TRANSFER SYSTEM AND RESPECTIVE OPERATION METHOD | AYAD, TAMIR | — |
| 18714018 | INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION | MCINTOSH III, TRAVISS C | — |
| 18700877 | SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS | LADD, CAROLYN LOUISE | — |
| 18686290 | METHOD FOR GENERATING NANOPARTICLES ON THE SURFACE OF A SUBSTRATE AND PART COMPRISING SUCH A SUBSTRATE | MILLER, MICHAEL G | — |
| 18418493 | ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES | WHITEMAN, BRIAN A | — |
| Art Unit | Apps |
|---|---|
| 1726 | 1 |
| 1622 | 1 |
| 1787 | 1 |
| 1636 | 1 |
| 1776 | 1 |
| 1691 | 1 |
| 1653 | 1 |
| 1621 | 1 |
| 2121 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19112100 | THERMOPLASMONIC DEVICE, RESPECTIVE WIRELESS ENERGY TRANSFER SYSTEM AND RESPECTIVE OPERATION METHOD | AYAD, TAMIR | 1726 | §102§103 | Non-Final OA | — | Pending | Mar 14, 2025 |
| 18714018 | INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION | MCINTOSH III, TRAVISS C | — | §102§112 | Non-Final OA | — | Pending | May 28, 2024 |
| 18711813 | ATTACHING NUCLEIC ACIDS TO A PLATINUM ELECTRODE | BELLAH, JEFFREY LAWRENCE | — | §103§112 | Non-Final OA | — | Pending | May 20, 2024 |
| 18700877 | SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS | LADD, CAROLYN LOUISE | 1622 | §103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18686290 | METHOD FOR GENERATING NANOPARTICLES ON THE SURFACE OF A SUBSTRATE AND PART COMPRISING SUCH A SUBSTRATE | MILLER, MICHAEL G | 1787 | §102§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18418493 | ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES | WHITEMAN, BRIAN A | 1636 | §112 | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18289512 | MESOPOROUS SOLID FOR CONTROLLING HUMIDITY IN ENCLOSED SPACES | MCKENZIE, THOMAS B | 1776 | §103 | Final Rejection | 17d overdue | Pending | Nov 03, 2023 |
| 18546348 | A PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLAMINES FROM POLYFLUOROALKYLALCOHOLS | SAWYER, JENNIFER C | 1691 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18013713 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | WHITE, ASHLEY TAYLOR | 1653 | §102§112 | Final Rejection | 19d | Pending | Dec 29, 2022 |
| 18001420 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT | NOTTINGHAM, KYLE GREGORY | 1621 | §112 | Non-Final OA | 28d | Pending | Dec 09, 2022 |
| 17632201 | HARDWARE ARCHITECTURE FOR SPIKING NEURAL NETWORKS AND METHOD OF OPERATING | PHAKOUSONH, DARAVANH | 2121 | §103 | Non-Final OA | — | Pending | Feb 01, 2022 |
| 16625834 | Method for Obtaining Haploid Cells | CONNORS, ALEXANDRA F | 1634 | §103 | Final Rejection | — | Pending | Dec 23, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial